ISRG insider files Form 144 to sell 125 shares

Myriam Curet McAdams filed a Form 144 reporting proposed and recent sales of Common stock of ISRG.

Rhea-AI Filing Summary

Myriam Curet McAdams filed a Form 144 reporting proposed and recent sales of Common stock of ISRG. The filing shows a proposed sale of 125 shares via a stock option exercise on 03/02/2026 for cash.

The filing also lists several sales by the same holder in the prior three months, including 2,345 shares on 02/27/2026 (1171819.95), 421 shares on 02/11/2026 (208378.16), and 105 shares on 02/10/2026 (51938.25).

Insights

Equity Capital Markets Analyst

Routine Form 144: insider proposes to sell shares following option exercise and recent dispositions.

The filing documents a proposed sale of 125 shares on 03/02/2026 tied to a stock option exercise, with proceeds designated as cash. This is a standard disclosure under resale notice rules.

Recent dispositions listed span 12/10/2025 through 02/27/2026, with the largest single reported sale of 2,345 shares on 02/27/2026 for 1171819.95. These provide context on near‑term insider liquidity; timing and further activity depend on holder decisions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ISRG Form 144 filed by Myriam Curet McAdams report?

It reports a proposed sale of 125 common shares via stock option exercise on 03/02/2026. The filing also lists multiple recent sales in the prior three months with share counts and gross proceeds documented.

How many shares did Myriam Curet McAdams sell on February 27, 2026?

She sold 2,345 shares on 02/27/2026, generating 1171819.95. The sale is recorded among several dispositions listed in the Form 144 covering December 2025 through February 2026.

What method is used for the proposed ISRG sale on March 2, 2026?

The proposed sale is through a stock option exercise on 03/02/2026, with proceeds in cash. The filing labels the transaction as an issuer-related option exercise resulting in a sale of 125 shares.

Do the Form 144 entries show proceeds amounts for recent sales?

Yes; the filing lists gross proceeds for each recent sale, for example 1171819.95 on 02/27/2026 and 208378.16 on 02/11/2026. Each sale line pairs share counts with corresponding proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001632901
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	INTUITIVE SURGICAL, INC.
SEC File Number	000-30713
Address of Issuer	1020 KIFER ROAD SUNNYVALE CALIFORNIA 94086
Phone	(408) 523-2100
Name of Person for Whose Account the Securities are To Be Sold	MYRIAM CURET MCADAMS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	125	61573.75	355130237	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Stock Option Exercise	ISSUER			125	03/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	02/27/2026	2345	1171819.95
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	02/11/2026	421	208378.16
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	02/10/2026	105	51938.25
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	01/29/2026	126	65522.52
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	01/27/2026	230	122500.30
MYRIAM CURET MCADAMS 1020 KIFER ROAD SUNNYVALE CA 94086	Common	12/10/2025	104	58229.60

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Myriam Curet McAdams
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)